These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26123948)

  • 21. A comprehensive approach to fragility fractures.
    Rebolledo BJ; Unnanuntana A; Lane JM
    J Orthop Trauma; 2011 Sep; 25(9):566-73. PubMed ID: 21654529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation and Treatment of Osteoporosis.
    O'Connor KM
    Med Clin North Am; 2016 Jul; 100(4):807-26. PubMed ID: 27235616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. People living with HIV and fracture risk.
    Premaor MO; Compston JE
    Osteoporos Int; 2020 Sep; 31(9):1633-1644. PubMed ID: 32206852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone alterations associated with HIV.
    Warriner AH; Mugavero M; Overton ET
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):233-40. PubMed ID: 25064454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis management and the utilization of FRAX®: a survey amongst health care professionals of the Asia-Pacific.
    Korthoewer D; Chandran M;
    Arch Osteoporos; 2012; 7():193-200. PubMed ID: 23225297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study.
    Pinzone MR; Castronuovo D; Di Gregorio A; Celesia BM; Gussio M; Borderi M; Maggi P; Santoro CR; Madeddu G; Cacopardo B; Nunnari G
    Infection; 2016 Apr; 44(2):197-203. PubMed ID: 26349915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Musculoskeletal disorders in HIV-infected patients.National AIDS Plan (PNS) and the AIDS Study Group (GESIDA)].
    Grupo de Expertos del Plan Nacional sobre el Sida y Grupo de Estudio de Sida
    Enferm Infecc Microbiol Clin; 2011; 29(7):515-23. PubMed ID: 21474209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E; Ursini T; Agostinone A; Di Nicola AD; Polilli E; Sozio F; Vadini F; Pieri A; Trave F; De Francesco V; Capasso L; Borderi M; Manzoli L; Viale P; Parruti G
    AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to predict the risk of fracture in HIV?
    Yin MT; Falutz J
    Curr Opin HIV AIDS; 2016 May; 11(3):261-7. PubMed ID: 26918651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoporosis In Turkish HIV/AIDS patients: comparative analysis by dual energy X-ray absorptiometry and digital X-ray radiogrammetry.
    Ozçakar L; Guven GS; Unal S; Akinci A
    Osteoporos Int; 2005 Nov; 16(11):1363-7. PubMed ID: 15824890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do people with HIV infection have a higher risk of fracture compared with those without HIV infection?
    Hoy J; Young B
    Curr Opin HIV AIDS; 2016 May; 11(3):301-5. PubMed ID: 26882459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks of osteoporosis associated with breast cancer treatment: the need to access to preventive treatment.
    Rozenberg S; Carly B; Liebens F; Antoine C
    Maturitas; 2009 Sep; 64(1):1-3. PubMed ID: 19709824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV and bone disease.
    Stone B; Dockrell D; Bowman C; McCloskey E
    Arch Biochem Biophys; 2010 Nov; 503(1):66-77. PubMed ID: 20682280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The skeletal muscle cross sectional area in long-term bisphosphonate users is smaller than that of bone mineral density-matched controls with increased serum pentosidine concentrations.
    Uchiyama S; Ikegami S; Kamimura M; Mukaiyama K; Nakamura Y; Nonaka K; Kato H
    Bone; 2015 Jun; 75():84-7. PubMed ID: 25708052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic approaches to the prevention and management of low bone mineral density in HIV-infected patients.
    Negredo E; Warriner AH
    Curr Opin HIV AIDS; 2016 May; 11(3):351-7. PubMed ID: 26890207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study.
    Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D
    Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of postmenopausal osteoporosis.
    Andreopoulou P; Bockman RS
    Annu Rev Med; 2015; 66():329-42. PubMed ID: 25386933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenofovir and bone health.
    Grant PM; Cotter AG
    Curr Opin HIV AIDS; 2016 May; 11(3):326-32. PubMed ID: 26859637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.